Neurable, the neurotechnology company democratizing BCI technology, announced today that it has raised an additional $13 million in funding from Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.

Neurable is a neurotechnology company that specializes in the development of AI-powered tools for brain signal translation and brain-computer interface technology. Powered by patented signal processing, developed through decades of pioneering research across leading labs and institutions, and advanced by a leading scientific and expert product team, the Neurable AI platform enables high-performance brain-computer interface in everyday devices. Neurable is dedicated to creating a world where individuals can overcome physical and mental limitations through innovative neurotechnology solutions.